These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17589130)

  • 1. The medically important yeasts present in clinical specimens.
    Al-Hedaithy SS
    Ann Saudi Med; 1992 Jan; 12(1):57-62. PubMed ID: 17589130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Presence of pathogenic yeasts in the feces of the semi-domesticated pigeon (Columba livia, Gmelin 1789, urban type) from the city of Turin].
    Gallo MG; Cabeli P; Vidotto V
    Parassitologia; 1989; 31(2-3):207-12. PubMed ID: 2487001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card.
    Dooley DP; Beckius ML; Jeffrey BS
    J Clin Microbiol; 1994 Dec; 32(12):2889-92. PubMed ID: 7883873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of yeasts in clinical specimens from cancer patients.
    Kiehn TE; Edwards FF; Armstrong D
    Am J Clin Pathol; 1980 Apr; 73(4):518-21. PubMed ID: 7369176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentially pathogenic yeasts from soil of children's recreational areas in the city of Łódź (Poland).
    Wójcik A; Kurnatowski P; Błaszkowska J
    Int J Occup Med Environ Health; 2013 Jun; 26(3):477-87. PubMed ID: 24018998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a commercial medium for identification of Candida species.
    San-Millán R; Ribacoba L; Pontón J; Quindós G
    Eur J Clin Microbiol Infect Dis; 1996 Feb; 15(2):153-8. PubMed ID: 8801088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two commercialized systems for the rapid identification of medically important yeasts.
    Quindós G; Lipperheide V; Pontón J
    Mycoses; 1993; 36(9-10):299-303. PubMed ID: 8015561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the new Mycotube test-kit for yeast identification.
    Guinet RM
    Eur J Clin Microbiol; 1985 Feb; 4(1):10-3. PubMed ID: 3886377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the new Micronaut-Candida system compared to the API ID32C method for yeast identification.
    Szabó Z; Tóth B; Kovács M; Kardos G; Maráz A; Rozgonyi F; Majoros L
    J Clin Microbiol; 2008 May; 46(5):1824-5. PubMed ID: 18322057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergenic cross-reactivity of yeasts.
    Koivikko A; Kalimo K; Nieminen E; Savolainen J; Viljanen M; Viander M
    Allergy; 1988 Apr; 43(3):192-200. PubMed ID: 3287997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of yeasts in pregnant and non-pregnant women in Nigeria.
    Gugnani HC; Nzelibe FK; Gini PC; Chukudebelu WO; Njoku-Obi AN
    Mycoses; 1989 Mar; 32(3):131-5. PubMed ID: 2733724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Pro-Lab ID ring system for the identification of medically important yeasts.
    Sekhon AS; Padhye AA; Garg AK; Rae R
    Mycopathologia; 1992 Jul; 119(1):11-6. PubMed ID: 1406902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal activity of phenylheptatriyne from Bidens cernua L. against yeasts.
    Rybalchenko NP; Prykhodko VA; Nagorna SS; Volynets NN; Ostapchuk AN; Klochko VV; Rybalchenko TV; Avdeeva LV
    Fitoterapia; 2010 Jul; 81(5):336-8. PubMed ID: 19837144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and emerging yeast pathogens.
    Hazen KC
    Clin Microbiol Rev; 1995 Oct; 8(4):462-78. PubMed ID: 8665465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
    Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of the Baxter MicroScan Yeast Identification Panel and the Vitek Yeast Biochemical Card.
    Riddle DL; Giger O; Miller L; Hall GS; Woods GL
    Am J Clin Pathol; 1994 Apr; 101(4):438-42. PubMed ID: 8160633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.